Unichem Pharmaceuticals USA Inc, a Hasbrouck Heights based specialty generic pharmaceutical company, announced yesterday that the company has named Scott Delaney as its new president and chief executive officer - North America for the Company's parent, Unichem Laboratories Limited, based in Mumbai, India.

Delaney has also been appointed as a member of the company's board of directors. The company says that he is an accomplished leader with more than 24 years of experience in brand and generic pharmaceutical management. He brings deep expertise in many areas of generic pharmaceutical management, including sales, marketing, contract negotiation, business development, manufacturing/distribution, third party payor management, product portfolio selection and product life cycle management. He has worked with organisations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, and Edenbridge Pharmaceuticals. He was president of Heritage Pharmaceuticals Inc, a division of Emcure Pharmaceuticals based in Pune, India.

Delaney said, 'I am honoured to accept the role of president and chief executive officer – North America for Unichem at this exciting time for the company. Dr Mody and the entire Unichem team, have been extremely welcoming to me and my family. They have built a tremendous organisation and are very well positioned for the future in the pharmaceutical industry. I look forward to continue to build on this success while helping to identify new and exciting opportunities that will create additional long-term value for Unichem Laboratories.'